Loss of new cell growth gene linked to certain human cancers

September 30, 2001

Researchers at Massachusetts General Hospital (MGH) have found that the loss of a recently discovered gene involved in cell growth may play an important role in the progression of some human cancers. The gene, called Cables, was discovered by the MGH team last year, and the latest results are published in the October 1 issue of Cancer Research.

"The Cables gene may be an important tumor suppressor gene located on chromosome 18," says principal investigator Lawrence Zukerberg, MD, of the MGH Department of Pathology. "People have known that a region of that chromosome is often missing in cancer cells, and they've been searching for cancer genes around that area for some time now."

Zukerberg and his colleagues found that the Cables gene is located on a chromosomal region that is frequently lost in colon, pancreatic, and squamous cancers. They also discovered that expression of the Cables protein is missing in these cancer cells. "We stained human tumor tissues such as colon and head and neck squamous cell carcinomas ? and found that 50 to 60 percent seem to be missing this protein," Zukerberg says.

The Cables protein normally acts to inhibit cell growth through a chain reaction effect. Cables prompts a protein called Wee1 to interact with another protein called cdk2, which plays a key role in encouraging cells to divide and grow. When it interacts with the Wee1 protein, however, cdk2's activity is diminished. So ultimately, expression of the Cables protein leads to decreased cell division.

Zukerberg's recent findings indicate that expression of the Cables protein may be important for thwarting the uncontrolled cell growth that is indicative of cancer. Without the protein, cells may be able to divide faster and could eventually become cancerous if they have a growth advantage over neighboring cells.

The next step for the MGH researchers is to try to prove that the Cables gene is a true tumor suppressor. They plan to knock out the gene in a mouse model to see if the effect leads to tumor development. They will also sequence the Cables gene from primary human tumor tissues to look for any potential mutations.
Other scientists involved in the study include Chin-Lee Wu, MD, PhD, Hua Xiao, MD, PhD, Daniel Chung, MD, Yenning Chuang, and Sandra Kirley. Laboratory support was provided by Scott McDougal, MD, Chief of Urology at MGH.

The Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $300 million and major research centers in AIDS, the neurosciences, cardiovascular research, cancer, cutaneous biology, photomedicine, transplantation biology. In 1994, the MGH joined with Brigham and Women's Hospital to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups and non acute and home health services.

Massachusetts General Hospital

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.